With the recognition that BC is indeed an immunogenic disease, multiple BC tumor-associated antigens (TAg’s), including Her2 and mucin 1 (Muc1), are being explored for potential vaccines for patients with extracranial BC tumors [105, 106]. Here, ERBB2 is linked to breast cancer.